Cheshire, CT, United States of America

Yuanqing Tang

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Melinta Therapeutics, Inc.. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuanqing Tang. Retrieved from https://idiyas.com/inventor/yuanqing-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yuanqing Tang

Introduction

Yuanqing Tang is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of antimicrobial compounds, holding a total of three patents. His work focuses on developing methods to treat and prevent microbial infections in both humans and animals.

Latest Patents

Yuanqing Tang's latest patents include innovative antimicrobial compounds and methods of making and using them. These inventions are designed to effectively treat, prevent, and reduce the risk of microbial infections, showcasing his commitment to advancing healthcare solutions.

Career Highlights

Yuanqing Tang is currently associated with Melinta Therapeutics, Inc., where he applies his expertise in antimicrobial research. His work at the company emphasizes the importance of developing effective treatments for infectious diseases.

Collaborations

Some of his notable coworkers include Erin M. Duffy and Ashoke Bhattacharjee, who contribute to the collaborative environment at Melinta Therapeutics, Inc. Their combined efforts enhance the research and development of innovative healthcare solutions.

Conclusion

Yuanqing Tang's contributions to antimicrobial research and his innovative patents reflect his dedication to improving health outcomes. His work continues to influence the field and offers promising advancements in the treatment of microbial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…